News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Tina Hovey

Articles by Tina Hovey

17 TROPION-Breast05: A Phase 3 Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Versus Chemotherapy (CT) Plus Pembrolizumab in Patients (pts) With PD-L1–Positive Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer (TNBC)

17 TROPION-Breast05: A Phase 3 Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Versus Chemotherapy (CT) Plus Pembrolizumab in Patients (pts) With PD-L1–Positive Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer (TNBC)

ByStephanie L. Graff, MD,Peter Schmid, MD,Massimo Cristofanilli, MD,David W. Cescon,Tina Hovey,Karson Tse,Petra Vuković,Joyce O’Shaughnessy, MD

August 11th 2024

Latest Updated Articles

Trending on CancerNetwork

New CAR T-Cell Therapy Earns FDA Breakthrough Status in T-Cell Malignancies

Zelenectide Pevedotin Displays Antitumor Activity in Advanced Solid Tumors

Zavabresib Earns FDA Orphan Drug Designation in Myelofibrosis

Median OS Not Yet Reached With New Immunotherapy Combo in 2L Glioblastoma

Decoding the Top Moments in Prostate Cancer Management From 2025